Company Overview - Xianle Health (SZ 300791) announced a total guarantee amount of approximately RMB 142 million for its controlling subsidiaries, with a guarantee balance of about RMB 134 million, representing approximately 5.33% of the company's most recent audited equity attributable to shareholders [1] - The total guarantee amount provided by the controlling subsidiaries to their own subsidiaries is approximately RMB 75.48 million, with a guarantee balance of about RMB 48.48 million, accounting for approximately 1.93% of the company's most recent audited equity attributable to shareholders [1] Revenue Composition - For the first half of 2025, Xianle Health's revenue composition is as follows: soft capsules 46.38%, gummies 25.31%, tablets 9.26%, functional beverages 5.42%, and hard capsules 5.31% [1] Market Capitalization - As of the announcement date, Xianle Health's market capitalization is RMB 7.8 billion [1]
仙乐健康:担保余额约为人民币约1.34亿元